Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists
Authors:
- Douglas W. MapelDMDouglas W. Mapel
- Judith S. HurleyJHJudith S. Hurley
- Douglas RoblinDRDouglas Roblin
- Melissa RobertsMRMelissa Roberts
- Kourtney J. DavisKDKourtney J. Davis
- Robert SchreinerRSRobert Schreiner
- Floyd J. FrostFFFloyd J. Frost
- 1 April 2006
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 100 (4) , 595-609
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Effects of Fluticasone on Systemic Markers of Inflammation in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEuropean Respiratory Journal, 2004
- The Effects of Inhaled Fluticasone on Airway Inflammation in Chronic Obstructive Pulmonary Disease: A Double-Blind, Placebo-controlled Biopsy StudyAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Cellular and Structural Bases of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Inhaled Corticosteroids in Stable COPD PatientsChest, 2000
- Inhaled Corticosteroids Are Not Beneficial in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Inhaled Corticosteroids Are Beneficial in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Are Inhaled Glucocorticosteroids Effective in Chronic Obstructive Pulmonary Disease?American Journal of Respiratory and Critical Care Medicine, 1999
- Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary diseaseThorax, 1998
- Effect of Fluticasone Propionate on Sputum of Patients With Chronic Bronchitis and EmphysemaAmerican Journal of Respiratory and Critical Care Medicine, 1996